Global Orthopedic Hyaluronic Acid Viscosupplementation Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Orthopedic Hyaluronic Acid Viscosupplementation Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Viscosupplementation is a medical treatment for knee osteoarthritis during which lubricating fluid is injected into the knee joint to reduce pain symptoms.
Orthopedic Hyaluronic Acid Viscosupplementation report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Orthopedic Hyaluronic Acid Viscosupplementation market is projected to reach US$ 2329.4 million in 2029, increasing from US$ 1822 million in 2022, with the CAGR of 3.6% during the period of 2024 to 2029. Demand from Hospitals and Clinics are the major drivers for the industry.
Viscosupplementation involves the injection of hyaluronic acid-based solutions into the joints to relieve pain and improve mobility in patients with osteoarthritis. Factors driving market growth include the increasing prevalence of osteoarthritis, growing aging population, and the effectiveness of viscosupplementation in managing symptoms. The market is highly competitive, with several manufacturers offering viscosupplementation devices. However, challenges such as limited insurance coverage, high treatment costs, and the availability of alternative therapies may hinder market expansion. Nonetheless, the viscosupplementation devices market holds promising opportunities, driven by the rising demand for non-surgical treatment options for osteoarthritis and ongoing research and development efforts to enhance the efficacy of viscosupplementation products.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Orthopedic Hyaluronic Acid Viscosupplementation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
Segment by Type
Single Injection
Three Injection
Five Injection
Hospitals
Clinics
Others
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Orthopedic Hyaluronic Acid Viscosupplementation market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Orthopedic Hyaluronic Acid Viscosupplementation, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Orthopedic Hyaluronic Acid Viscosupplementation industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Orthopedic Hyaluronic Acid Viscosupplementation in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Orthopedic Hyaluronic Acid Viscosupplementation introduction, etc. Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Orthopedic Hyaluronic Acid Viscosupplementation market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Orthopedic Hyaluronic Acid Viscosupplementation report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Orthopedic Hyaluronic Acid Viscosupplementation market is projected to reach US$ 2329.4 million in 2029, increasing from US$ 1822 million in 2022, with the CAGR of 3.6% during the period of 2024 to 2029. Demand from Hospitals and Clinics are the major drivers for the industry.
Viscosupplementation involves the injection of hyaluronic acid-based solutions into the joints to relieve pain and improve mobility in patients with osteoarthritis. Factors driving market growth include the increasing prevalence of osteoarthritis, growing aging population, and the effectiveness of viscosupplementation in managing symptoms. The market is highly competitive, with several manufacturers offering viscosupplementation devices. However, challenges such as limited insurance coverage, high treatment costs, and the availability of alternative therapies may hinder market expansion. Nonetheless, the viscosupplementation devices market holds promising opportunities, driven by the rising demand for non-surgical treatment options for osteoarthritis and ongoing research and development efforts to enhance the efficacy of viscosupplementation products.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Orthopedic Hyaluronic Acid Viscosupplementation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
Segment by Type
Single Injection
Three Injection
Five Injection
Segment by Application
Hospitals
Clinics
Others
Segment by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Orthopedic Hyaluronic Acid Viscosupplementation market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Orthopedic Hyaluronic Acid Viscosupplementation, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Orthopedic Hyaluronic Acid Viscosupplementation industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Orthopedic Hyaluronic Acid Viscosupplementation in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Orthopedic Hyaluronic Acid Viscosupplementation introduction, etc. Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Orthopedic Hyaluronic Acid Viscosupplementation market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices